Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Scully

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Managed Care (Langhorne, Pa.)|June 14, 2002
'Real change' in system won't come overnight. Interview by Patrick MullenThomas Scully
Health Affairs (Project Hope)|April 4, 2003
A call to excellenceCarolyn M Clancy, Thomas Scully
Journal of Imaging|September 26, 2021
A Low Redundancy Wavelet Entropy Edge Detection AlgorithmYiting Tao, Thomas Scully, Asanka G Perera, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 22, 2022
Augmented Renal Clearance of Vancomycin in Suspected Sepsis: Single-Center, Retrospective Pediatric CohortPeter Thomas Scully, Weng Man Lam, Alvaro Jose Coronado Munoz, et al.
American Journal of Physical Medicine & Rehabilitation|May 31, 2023
Upper Limb Spasticity: The Quality of Online Patient ResourcesTyler Larkin, Victor Martinez, Thomas Scully, et al.
ACS Applied Materials & Interfaces|September 29, 2022
Wafer-Scale Full-Coverage Self-Limiting Assembly of Particles on Flexible SubstratesLiang Zhao, Bchara Sidnawi, Jichao Fan, et al.
Cancer Chemotherapy and Pharmacology|August 16, 2017
Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastomaMichael A Badruddoja, Marjorie Pazzi, Abhay Sanan, et al.
Cancer Chemotherapy and Pharmacology|October 17, 2017
Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastomaMichael A Badruddoja, Marjorie Pazzi, Abhay Sanan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Managed Care (Langhorne, Pa.)|June 14, 2002
'Real change' in system won't come overnight. Interview by Patrick MullenThomas Scully
Health Affairs (Project Hope)|April 4, 2003
A call to excellenceCarolyn M Clancy, Thomas Scully
Journal of Imaging|September 26, 2021
A Low Redundancy Wavelet Entropy Edge Detection AlgorithmYiting Tao, Thomas Scully, Asanka G Perera, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|February 22, 2022
Augmented Renal Clearance of Vancomycin in Suspected Sepsis: Single-Center, Retrospective Pediatric CohortPeter Thomas Scully, Weng Man Lam, Alvaro Jose Coronado Munoz, et al.
American Journal of Physical Medicine & Rehabilitation|May 31, 2023
Upper Limb Spasticity: The Quality of Online Patient ResourcesTyler Larkin, Victor Martinez, Thomas Scully, et al.
ACS Applied Materials & Interfaces|September 29, 2022
Wafer-Scale Full-Coverage Self-Limiting Assembly of Particles on Flexible SubstratesLiang Zhao, Bchara Sidnawi, Jichao Fan, et al.
Cancer Chemotherapy and Pharmacology|August 16, 2017
Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastomaMichael A Badruddoja, Marjorie Pazzi, Abhay Sanan, et al.
Cancer Chemotherapy and Pharmacology|October 17, 2017
Correction to: Phase II study of bi-weekly temozolomide plus bevacizumab for adult patients with recurrent glioblastomaMichael A Badruddoja, Marjorie Pazzi, Abhay Sanan, et al.
Pageof 1